Skip to main content
Premium Trial:

Request an Annual Quote

Roche Dx Licenses Multilyte’s Multiparameter Binding Assay IP

NEW YORK (GenomeWeb News) - Roche Diagnostics today said it has signed a licensing agreement with Multilyte for access to Multilyte's patents for diagnostic assays.
 
Roche will pay a license fee and royalties from the sale of products covered by Multilyte’s patents.
 
Assays covered under the patents include mulitparameter binding assays, including immunoassays, to enable “simultaneous detection and analysis of many different analytes in small test samples of biological origin,” Roche said.
 
Roche said that the agreement will enable it to develop microarray-based immunoassays and other binding assay systems that will detect multiple analytes in a single reaction.
 
Multilyte was founded in 1988 as a spin-off from University College London by UCL biophysics professor Roger Ekins.

The Scan

Study Finds Sorghum Genetic Loci Influencing Composition, Function of Human Gut Microbes

Focusing on microbes found in the human gut microbiome, researchers in Nature Communications identified 10 sorghum loci that appear to influence the microbial taxa or microbial metabolite features.

Treatment Costs May Not Coincide With R&D Investment, Study Suggests

Researchers in JAMA Network Open did not find an association between ultimate treatment costs and investments in a drug when they analyzed available data on 60 approved drugs.

Sleep-Related Variants Show Low Penetrance in Large Population Analysis

A limited number of variants had documented sleep effects in an investigation in PLOS Genetics of 10 genes with reported sleep ties in nearly 192,000 participants in four population studies.

Researchers Develop Polygenic Risk Scores for Dozens of Disease-Related Exposures

With genetic data from two large population cohorts and summary statistics from prior genome-wide association studies, researchers came up with 27 exposure polygenic risk scores in the American Journal of Human Genetics.